(Q50921579)

25 March 2018

MDMA

0 references

title

The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. (English)

1 reference

25 March 2018

1 reference

Manuel Tancer

1

1 reference

25 March 2018

Chris-Ellyn Johanson

series ordinal

2

1 reference

25 March 2018

publication date

18 October 2006

1 reference

25 March 2018

number of pages

9

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

25 March 2018

volume

189

1 reference

25 March 2018

issue

4

1 reference

25 March 2018

page(s)

565-573

1 reference

25 March 2018

Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-006-0576-Z

The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine

21 January 2018

1 reference

12 December 2020

Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors

1 reference

12 December 2020

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans

1 reference

12 December 2020

MDMA induced dopamine release in vivo: role of endogenous serotonin

1 reference

12 December 2020

Discriminative profile of MDMA.

1 reference

12 December 2020

Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP

1 reference

12 December 2020

The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system

1 reference

12 December 2020

Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo

1 reference

12 December 2020

Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans

1 reference

12 December 2020

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

12 December 2020

The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release

1 reference

12 December 2020

Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans

1 reference

12 December 2020

Drug discrimination studies with MDMA and amphetamine

1 reference

12 December 2020

A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (+/-)-MDMA in rats.

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement

1 reference

12 December 2020

The subjective effects of MDMA and mCPP in moderate MDMA users

1 reference

12 December 2020

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

1 reference

12 December 2020

5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents

1 reference

12 December 2020

Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects

1 reference

12 December 2020

Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons.

1 reference

12 December 2020

Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination.

1 reference

12 December 2020

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.

1 reference

12 December 2020

Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data

1 reference

12 December 2020

Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.

1 reference

12 December 2020

Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs

1 reference

12 December 2020

Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") may be separable from its neurotoxic actions: clinical evidence.

1 reference

12 December 2020

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

1 reference

12 December 2020

Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3,4-methylenedioxymethamphetamine; MDMA)

1 reference

12 December 2020

Altered states: the clinical effects of Ecstasy.

1 reference

12 December 2020

Serotonergic-dopaminergic mediation of MDMA's discriminative stimulus effects in a three-choice discrimination

1 reference

12 December 2020

Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers

1 reference

12 December 2020

High dose pimozide does not block amphetamine-induced euphoria in normal volunteers.

1 reference

12 December 2020

The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline.

1 reference

12 December 2020

Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans

1 reference

12 December 2020

The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats

1 reference

12 December 2020

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

1 reference

12 December 2020

N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').

1 reference

12 December 2020

The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA).

1 reference

12 December 2020

10.1007/S00213-006-0576-Z

Identifiers

DOI

1 reference

25 March 2018

1 reference

25 March 2018